China Exhibition design and construction company

About Exhibition design and construction   Contact China Exhibition design    |   

Zhonghan Shengtai participates in the China International Laboratory Medicine Expo - JOINEXPO Exhibition Construction Company

Hangzhou/

Zhonghan Shengtai participates in the China International Laboratory Medicine Expo

Exhibition area: 135 square meters
Exhibition location: Hangzhou, China
Exhibition time: 2022-03-22-2025-03-24
Industry Category: Medical Equipment Exhibition
Exhibition venue: Hangzhou Grand Convention and Exhibition Center
Exhibition booth style: modern and minimalist
Designer: Terry
Project Manager: Sky
Exhibition Name: China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo

  • Product Details
  • China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo

1、 Deeply cultivate the field of medical diagnosis and create a full industry chain ecosystem
Zhonghan Shengtai Biotechnology Co., Ltd. was established in 2010 and is headquartered in Hangzhou. It is a high-tech biopharmaceutical enterprise specializing in the field of in vitro diagnostics (IVD) for the entire industry chain. The company integrates research and development, production, sales, service, and technology incubation, covering multiple fields such as POCT (real-time testing), biochemistry, immunology, molecular diagnostics, and extending to third-party testing, bioinformatics technology services, and medical device cold chain logistics, building an ecosystem strategy of “one main, two wings, and dual core drive”. At present, the company has more than 400 employees, with 60% having a bachelor’s degree or above. It has a production base of 25000 square meters and a public experimental platform of 1700 square meters, with an annual production capacity of 40 million sets of diagnostic kits.

2、 Hardcore technology platform, leading industry innovation
Zhonghan Shengtai is driven by technology as its core, and has achieved multiple results to fill industry gaps:

1. Fully automatic rapid immunoassay system: the world’s first open detection platform that supports multiple sample types such as whole blood, serum, and plasma. It can complete emergency immune testing in 20 minutes, greatly reducing patient waiting time. This platform integrates multiple indicator modules (such as comprehensive diagnosis of chest pain), which can cover multiple needs with one test. It has obtained 14 patents and been selected as a national science and technology support project.
2. IMatrix fully automatic high-throughput liquid phase chip platform: combining high-throughput detection and intelligent management, with a single machine detection speed of up to 240T/hour, flexible adaptation to desktop, landing, and assembly line modes, meeting diverse inspection scene requirements.
3. Individualized medical navigation system: Through genetic testing and bioinformatics analysis, it provides precise navigation for targeted cancer therapy, helping to tailor diagnosis and treatment plans accordingly.

The company has accumulated more than 30 patents, and its products have won honors such as “Zhejiang Province’s First (Set) Equipment” and “China In Vitro Diagnostic Innovation Product Gold Award”. The technology has been recognized as “international advanced level”.

3、 Global cooperation and industry recognition showcase brand strength
Zhonghan Shengtai has won widespread recognition for its outstanding innovation capabilities and market performance

1. International Cooperation: In depth exchanges with international organizations such as the German Chinese Education and Culture Association in North Rhine Westphalia, Germany, to promote the integration of technology between China and Germany; Reached a strategic investment partnership with Morgan Stanley to accelerate global expansion.
2. Industry Honors: Selected for the “Kunpeng” Enterprise List in Linping District, Hangzhou City, and awarded titles such as “Forbes China Top 100 Potential Non listed Enterprises” and “First (Set) Product in Key Fields of Equipment Manufacturing Industry in Zhejiang Province”.
3. Exhibition influence: As a core exhibitor of international level exhibitions such as the Zhejiang Spring Medical Exhibition, showcasing innovative platforms such as iMatrix and Jet iStar, attracting global customer attention.

4、 Practice social responsibility and convey the power towards goodness
Zhonghan Shengtai has always been committed to the mission of “focusing on medical diagnosis and serving human health”, actively participating in public welfare undertakings:

1. Education support: Since 2010, for every 1000 devices sold, we have donated to build a “Aikemei Hope Primary School”, which has covered areas such as Heilongjiang, Guangxi, and Jiangxi, benefiting thousands of children.
2. Medical assistance: Donate medical equipment to Naqu, Xizang, Haixi, Qinghai and other regions, carry out the “inspection technology to the countryside” activity, and improve the level of grass-roots diagnosis and treatment.
3. Charity Honor: Mr. Zhou Xuyi, the Chairman, was awarded the title of “Top Ten Charitable Entrepreneurs in Zhejiang”. The company has participated in public welfare projects such as “Spring Breeze Action” and “99 Public Welfare Day” for many years, spreading positive social energy.

5、 Putting people first, building an excellent team and culture
The company focuses on employee growth and well-being, and creates a comprehensive talent development system:

1. Dual channel promotion: parallel development of technology and management, providing platforms such as postdoctoral workstations and school enterprise cooperation to assist in the transformation of scientific research.
2. Diversified benefits: including five insurances and one fund, annual physical examination, catering and transportation subsidies, as well as leisure facilities such as fitness centers and libraries, creating a healthy working environment.
3. Integration of Party Building and Public Welfare: By organizing activities such as red education and voluntary blood donation through the Party Committee, Trade Union, and Youth League Committee, the team’s cohesion is strengthened.

6、 Future Vision: Empowering Health with Technology and Building a New Era of Precision Medicine Together
Zhonghan Shengtai will continue to deepen the integration of “AI+diagnostic technology” and promote early screening and precise treatment of major diseases such as sepsis and tumors. Relying on the location advantage of the demonstration zone for aviation economy, the company will further expand its international market, join hands with global partners, and inject innovative momentum into the cause of human health.

Hangzhou CACLP (China International Laboratory Medicine and In Vitro Diagnostic Reagent Exhibition), as the largest and most influential event in the in vitro diagnostic industry in Asia, has always been committed to the mission of "connecting global technology and driving industrial upgrading". It gathers top enterprises, cutting-edge technologies, and industry elites from around the world, and creates an international platform that integrates exhibitions, forums, commerce, and cooperation. In 2024, Hangzhou CACLP will once again set sail, with digital empowerment and full industry chain coverage as its core, opening an innovative feast for the in vitro diagnostic industry!

1、 Global resource aggregation, empowering industrial ecology
1. Leading scale: Over 1000 globally renowned enterprises participated in the exhibition, covering the entire IVD industry chain - from core raw materials, diagnostic equipment to intelligent solutions, presenting the latest technological achievements in the industry;
2. International Participation: Attracting more than 30 national pavilions from Europe, America, Asia Pacific, and other regions to promote cross-border technological exchanges and business cooperation;
3. Precise docking: Relying on AI intelligent algorithms, we accurately match the needs of exhibitors with over 100000 professional visitors (medical institutions, distributors, research institutions) and efficiently leverage business opportunities.

2、 Cutting edge technology trends define the future of the industry
1. Innovation Release Platform: Launch the "CACLP Global Innovation Product List", focusing on molecular diagnostics POCT、 Hot topics such as liquid biopsy lead technological changes;
2. Top Forum Matrix: Over 50 summit forums covering topics such as "precision medicine," "smart laboratories," and "domestic substitution strategies," gathering academicians, experts, and business leaders to discuss trends;
3. Industry university research integration: Jointly organize the "Industry university research cooperation docking meeting" with institutions such as Zhejiang University and the Chinese Academy of Sciences to accelerate the transformation and implementation of scientific and technological achievements.

3、 Supported by Hangzhou's advantages, activate the growth engine
1. Location Empowerment: Based on the highland of the biopharmaceutical industry in the Yangtze River Delta, we enjoy the policy dividends and industrial cluster advantages of Hangzhou's digital economy;
2. Ecological synergy: linking Hangzhou Pharmaceutical Port Town and Biomedical Industry Park to create a one-stop industrial service ecosystem of "exhibition+park+capital";
3. Digital experience: Online offline integration (O2O) mode, providing functions such as "cloud exhibition hall" and "online negotiation", breaking through time and space limitations, and reaching global users.

4、 Upgrading the exhibition value and achieving a win-win trillion dollar market
1. Brand exposure: Covering over 200 industry media outlets, authoritative reports from CCTV, Xinhua News Agency, etc., to enhance global brand awareness;
2. Policy Direct: Interpreting the latest regulations and industry standards in the IVD field to assist enterprises in compliance and international layout;
3. Capital docking: Establish a "IVD Innovation Project Roadshow" to connect top investment institutions such as Sequoia Capital and Hillhouse, empowering enterprise growth.

Next:

Leave a Reply

Leave a message